{"id":"W1956657204","doi":"10.1200/jco.2013.31.6_suppl.6","title":"Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Université de Montréal","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Clinical endpoint; Placebo; Internal medicine; Docetaxel; Adverse effect; Concomitant; Abiraterone acetate; Oncology; Urology; Cancer; Randomized controlled trial; Androgen receptor; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00300991,0.0001628017,0.001427989,0.0001656605,0.00003843181,0.00001358211,0.0001820011,0.0001649551,0.0001011454],"category_scores_gemma":[0.001751127,0.00007908779,0.0002142077,0.0002041807,0.0002168959,0.0001556405,0.00005012474,0.0009633648,0.00000438851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001683934,"about_ca_system_score_gemma":0.0005830838,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002921855,"about_ca_topic_score_gemma":0.0001018663,"domain_scores_codex":[0.9954731,0.001340827,0.002182586,0.0002152952,0.0005557152,0.0002324177],"domain_scores_gemma":[0.9940084,0.003870004,0.001121797,0.0003278183,0.0003586102,0.0003134127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08369541,0.1047323,0.7038212,0.00001352072,0.0008447376,0.0003870742,0.004042289,0.00002844022,0.001146507,0.000002352254,0.0006214564,0.1006646],"study_design_scores_gemma":[0.07181422,0.2730022,0.6519741,0.00008082708,0.0001785653,0.0000308928,0.002579282,0.00001843628,0.0001166136,0.000006362161,0.0001496854,0.00004879561],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971114,0.0001131575,5.370606e-7,0.0006810816,0.0001702378,0.001829802,0.000008520115,0.000002889208,0.00008234234],"genre_scores_gemma":[0.9991295,0.000325494,0.00003678562,0.0001865381,0.0002667449,0.00001293306,0.000002965449,0.00001346432,0.00002559002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1682699,"threshold_uncertainty_score":0.4185394,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1868019128820495,"score_gpt":0.5268007643341991,"score_spread":0.3399988514521496,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}